Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma.

Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Abstract Text:

    xiao z shenXiao Z Shen,ping liPing Li,daiana weissDaiana Weiss,sebastien fuchsSebastien Fuchs,hong d xiaoHong D Xiao,jon a adamsJon A Adams,ifor r williamsIfor R Williams,mario r capecchiMario R Capecchi,w robert taylorW Robert Taylor,kenneth e bernsteinKenneth E Bernstein,

    Angiotensin-converting enzyme (ACE) is a peptidase responsible for the cleavage of angiotensin I and several other peptides. Here, gene targeting was used to switch control of the ACE locus from the endogenous promoter to the macrophage-specific c-fms promoter. Challenge of these mice, called ACE 10/10, with the aggressive mouse melanoma cell line B16 showed that they are remarkably resistant to tumor growth. Tumor resistance was seen after challenge with different melanoma cell lines and in mice with different genetic backgrounds. Histological study of the tumors that did grow in ACE 10/10 mice showed an enhanced inflammatory response. ACE 10/10 mice had increased numbers of tumor epitope-specific CD8(+) T cells after challenge with melanoma or lymphoma. ACE 10/10 macrophages showed increased production of interleukin-12 and nitric oxide but reduced interleukin-10. Engraftment of wild-type mice with ACE 10/10 bone marrow transferred B16 tumor resistance. Injection of B16 tumors with ACE 10/10 macrophages also reduced tumor growth. ACE 10/10 mice may define a new means of enhancing the immune response, which may be potentially useful in several human clinical situations.

    Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Publishing Authors By Initials

    xz shenXZ Shen,p liP Li,d weissD Weiss,s fuchsS Fuchs,hd xiaoHD Xiao,ja adamsJA Adams,ir williamsIR Williams,mr capecchiMR Capecchi,wr taylorWR Taylor,ke bernsteinKE Bernstein,

    For similar biochemical phenomena, metabolism, and nutrition: metabolism: pharmacokinetics: tissue distribution research abstracts see: biochemical phenomena, metabolism, and nutrition: metabolism: pharmacokinetics: tissue distribution research

    PUBMED ID PMID:

    MEDLINE DATE:

    Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The American journal of pathology

    VOLUME: 170

    Page Numbers: 2122-34

    Journal Abbreviation: Am. J. Pathol.

    ISSN: 0002-9440

    DAY: 3

    MONTH: Jun

    YEAR: 2007

    Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370502

    Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Keywords Mesh Terms:

    KEYWORDS: Tissue Distribution

    MESH TERMS: pathology

    Chemical & Substance for Abstract: Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Information

    Substance Name: Renin

    Registry Number: EC 3.4.23.15

    Grant and Affiliation Information for Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma.

    AFFILIATION: Department of Pathology and Laboratory Medicine, Emory University, 101 Woodruff Circle, Atlanta, GA 30322, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDDK

    GRANT: R37 DK 039777

    ACRONYM: DK

    MEDLINETA: Am J Pathol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News